These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1788763)

  • 21. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term clinical results after coronary artery bypass surgery.
    Bourassa MG
    Cardiovasc Clin; 1991; 21(2):101-21. PubMed ID: 2044085
    [No Abstract]   [Full Text] [Related]  

  • 23. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 24. Aortocoronary saphenous vein bypass grafts.
    Virmani R; Atkinson JB; Forman MB
    Cardiovasc Clin; 1988; 18(2):41-62. PubMed ID: 3275420
    [No Abstract]   [Full Text] [Related]  

  • 25. Left ventricular function after coronary bypass surgery.
    Bourassa MG
    Cardiovasc Clin; 1991; 21(2):227-37. PubMed ID: 2044090
    [No Abstract]   [Full Text] [Related]  

  • 26. Interpretation of Dutch BOA trial. Dutch Bypass Oral anticoagulants or Aspirin study group.
    Algra A; Tangelder MJ; Lawson JA; Eikelboom BC
    Lancet; 2000 Apr; 355(9210):1186-7. PubMed ID: 10791406
    [No Abstract]   [Full Text] [Related]  

  • 27. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Urquhart J; Thijssen H; Struijker Boudier HA
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):46-7. PubMed ID: 8289961
    [No Abstract]   [Full Text] [Related]  

  • 28. Reoperation for coronary artery bypass grafting.
    Carrier M; Perreault L; Pelletier LC
    Cardiovasc Clin; 1991; 21(2):257-63. PubMed ID: 2044093
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2223. PubMed ID: 8247171
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future implications of current trends in bypass surgery.
    Lytle BW; Cosgrove D; Loop FD
    Cardiovasc Clin; 1991; 21(2):265-78. PubMed ID: 2044094
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of venous thrombosis and embolism of the pulmonary artery in the postoperative period (review of the literature)].
    Pavlovskiĭ DP
    Khirurgiia (Mosk); 1988 Dec; (12):148-51. PubMed ID: 3070125
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antithrombotic agents in coronary bypass surgery in The Netherlands].
    Galema TW; Verheugt FW
    Ned Tijdschr Geneeskd; 1990 Aug; 134(34):1632-6. PubMed ID: 2215703
    [No Abstract]   [Full Text] [Related]  

  • 35. Invited commentary.
    Hiratzka LF
    Ann Thorac Surg; 2010 Nov; 90(5):1521-2. PubMed ID: 20971253
    [No Abstract]   [Full Text] [Related]  

  • 36. Off-pump coronary bypass surgery: another brick in the wall of reduced graft patency.
    Parolari A; Tremoli E; Biglioli P; Alamanni F
    Ann Thorac Surg; 2009 Feb; 87(2):675-6; author reply 676. PubMed ID: 19161824
    [No Abstract]   [Full Text] [Related]  

  • 37. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

  • 38. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Houben JJ; Nicolai G
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment alternatives for chronically occluded saphenous vein grafts.
    Heuser RR
    J Invasive Cardiol; 1995 May; 7(4):94-6. PubMed ID: 10158110
    [No Abstract]   [Full Text] [Related]  

  • 40. Unstable angina: special considerations in the postbypass patient.
    Théroux P; Waters D
    Cardiovasc Clin; 1991; 21(2):169-91. PubMed ID: 2044088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.